Morocco vs Saint Lucia: Prevalence rate of diabetes in adults
Morocco
13.7
in 2014
Saint Lucia
14.5
in 2014
Morocco rank
26th
Saint Lucia rank
23rd
Prevalence rate of diabetes in adults over time
- Morocco
- Saint Lucia
How they compare
Saint Lucia currently reports 14.5 against 13.7 in Morocco, a difference of 0.8.
That makes Saint Lucia's figure about 1.1 times Morocco's.
The two have swapped places 1 time across 35 shared years of data; in 1980 it was Morocco ahead.
Morocco ranks 26th and Saint Lucia ranks 23rd of 190 countries.
Across the 4 decades both report, Morocco averaged higher in 3 and Saint Lucia in 1.
Head to head by decade
| Decade | Morocco | Saint Lucia | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 5.86 | 4.72 | 1.14 | Morocco |
| 1990s | 7.7 | 6.68 | 1.02 | Morocco |
| 2000s | 10.48 | 9.79 | 0.69 | Morocco |
| 2010s | 12.98 | 13.32 | 0.34 | Saint Lucia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of diabetes in adults, Morocco or Saint Lucia?
- Saint Lucia, at 14.5 against 13.7 in Morocco as of 2014.
- What is the difference in prevalence rate of diabetes in adults between Morocco and Saint Lucia?
- 0.8, with Saint Lucia ahead.
- How many years of comparable data are there for Morocco and Saint Lucia?
- 35 years are reported by both, from 1980 to 2014.
- How do Morocco and Saint Lucia rank globally for prevalence rate of diabetes in adults?
- Morocco ranks 26th and Saint Lucia ranks 23rd of 190 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of diabetes in adults. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of people with diabetes among those aged over 18, based on general population surveys and statistical modeling. Diabetes is a risk factor for chronic complications, including cardiovascular disease, and premature death.